# AMPICILLIN AND SULBACTAM
> **ANDA065314** · Abbreviated New Drug Application (Generic) · Sponsor: ISTITUTO BIO ITA SPA · Approved 2006-11-27
## Drug
- **FDA Application Number:** ANDA065314
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMPICILLIN AND SULBACTAM
- **Generic name:** AMPICILLIN AND SULBACTAM
- **Active ingredients:** AMPICILLIN SODIUM; SULBACTAM SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ISTITUTO BIO ITA SPA
- **Manufacturer:** Avenacy, LLC
- **First approval:** 2006-11-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065314)
---
*MORVS · CC0 1.0*